1. Introduction {#sec1-foods-08-00580}
===============

Two varieties of sour lime, namely Key or Mexican (*Citrus aurantifolia* Swingle) and Persian (*Citrus latifolia* Tanaka), find wide use in the flavor industry. Distilled Key lime oil is the most common product, with its aroma deriving from transformation processes (hydration, elimination, rearrangement reactions) which occur during the distillation process. Cold-pressed lime oil is characterized by a fragrant citrus aroma and is used in perfumery, as well as in the flavor industry. Different types of cold-pressing processes provide different types of lime oils: (I) a screw press is used to attain a juice--oil--pulp mixture, followed by centrifugation to isolate the essential oil. Such a procedure is used only for Key limes and yields the type A oil; (II) the peel is subjected to gentle grating, with the oil washed away through the application of water. After, the oil is recuperated through centrifugation. Such a process is applied to both Key (type B oil) and Persian limes \[[@B1-foods-08-00580]\].

The volatile fraction of lime oils is lower than other cold-pressed citrus oils (e.g., 85% against 99% of sweet orange oil), and is composed of a variety of mono- and sesquiterpenes (both hydrocarbons and oxygenated), along with aliphatic alkanes, alcohols, and aldehydes \[[@B2-foods-08-00580]\].

Gas chromatography--mass spectrometry (GC-MS) is certainly the prime analytical choice for the qualitative untargeted analysis of the volatile fraction of lime essential oil; identification is often achieved through MS database matching, the use of linear retention index (LRI) information, and the co-injection of pure standard compounds. The GC-MS analysis is commonly performed using a conventional (i.e., 30 m × 0.25 mm ID × 0.25 μm d~f~) low-polarity column and a unit-mass resolution mass spectrometer \[[@B2-foods-08-00580],[@B3-foods-08-00580]\].

Even though the utility of GC-MS is not herein doubted, it has been previously shown that the on-line combination of normal phase liquid chromatography (NP-LC), and GC-MS is of high analytical usefulness within the context of lime essential oil analysis, and more in general in that of essential oils. The NP-LC process achieves a polarity-based separation, thus isolating the hydrocarbons from the oxygenated compounds. After each fraction is subjected to a GC-MS analysis, reducing the chance of co-elution, and thus increasing the number of separated compounds \[[@B4-foods-08-00580]\].

A great increase in the number of separated compounds can also be attained by using comprehensive two-dimensional GC-MS (GC × GC-MS). In GC × GC analyses, a dedicated transfer device (a cryogenic modulator in the majority of cases) is used to first cut, and then transfer fractions of effluent from a first analytical column (usually a conventional column) onto a second one (usually a short micro-bore column segment (1--2 m)) with a different stationary phase. Such a transfer (or modulation) process occurs sequentially, and in a continuous manner, throughout the analysis. The superiority of GC × GC, over conventional GC, is due to the: (I) enhanced selectivity; (II) increased separation power; (III) high sensitivity due to analyte re-concentration (if cryogenic modulation is used); (IV) pattern formation of homologous series of compounds (e.g., alkanes, fatty acid methyl esters, etc.), enhancing the reliability of identification. Comprehensive 2D GC was first introduced in 1991 \[[@B5-foods-08-00580]\], can now be considered as a well-known technology \[[@B6-foods-08-00580]\], and has been used both for the analysis of non-citrus and citrus essential oils \[[@B7-foods-08-00580],[@B8-foods-08-00580]\].

With the aim of exploiting the benefits of both LC and GC × GC (with single quadrupole (Q) MS), in previous off-line research the two technologies were combined (LC//GC × GC-QMS) and used for the highly-detailed qualitative analysis of sweet orange and bergamot essential oils \[[@B9-foods-08-00580]\]. Later studies were focused on a highly specific albeit minor chemical class (sesquiterpene hydrocarbons) of lemon, bergamot, sweet orange, clementine, bitter orange, mandarin (green, yellow, red), pink grapefruit, and lime (Key A, Key B, and Persian) essential oils \[[@B10-foods-08-00580]\], and on the oxygenated constituents of green, yellow, and red mandarin oils \[[@B11-foods-08-00580]\].

In the present research, LC//GC × GC-QMS was used for the highly detailed qualitative profiling of the entire volatile fraction of Key A, Key B, and Persian lime oils. The scope of the study is to demonstrate and confirm the analytical power and potential of such a technique, in this case applied to lime essential oil. For such a reason, the research involved one of each type of lime essential oil.

2. Experimental {#sec2-foods-08-00580}
===============

2.1. Samples and Sample Preparation {#sec2dot1-foods-08-00580}
-----------------------------------

A C~7~-C~30~ *n*-alkane series was kindly provided by Merck Life Science (Merck KGaA, Darmstadt, Germany) for the calculation of LRI values.

Three genuine cold-pressed samples of lime (Key A, Key B, and Persian) oils were provided by Citrojugo S.A. de C.V. Tecomán (Colima, Mexico). Prior to LC analyses, the oils were diluted 1:2 (*v*/*v*) in hexane.

2.2. LC Pre-Separation {#sec2dot2-foods-08-00580}
----------------------

LC pre-separations were performed on the lime essential oils using the Shimadzu 5D Ultra-e system (Kyoto, Japan) consisting of:

\(1\) An LC system, equipped with a CBM-20A communication bus module, two LC-30AD dual-plunger parallel-flow pumps, a DGU-20A online degasser, an SPD-M20A photodiode array detector, a CTO-20A column oven, and an SIL-30AC autosampler. Data were acquired by the LC solution v.5.92 software (Shimadzu).

\(2\) An AOC-5000 auto injector equipped with a dedicated dual side-port syringe, employed as a transfer device (not used in the present investigation). LC fractions were collected by disconnecting the transfer line (linking the outlet of the LC detector to the syringe) from the syringe side.

LC conditions: a 100 × 3 mm ID × 5 µm d~p~ silica column (SUPELCOSIL LC-Si, Merck Life Science) was operated under the following gradient conditions (flow: 0.35 mL min^−1^): 0--4.5 min (100% hexane); from 4.5 to 6.0 min 100% MTBE (until the end of the analysis). Injection volume: 20 µL.

LC fractions: hydrocarbons were collected from 1.5 to 3 min (525 µL); oxygenated compounds were collected from 7.3 to 14 min (2345 µL).

Prior to GC × GC-QMS injection, the fractions were reduced to a volume of 100 µL (under a gentle stream of nitrogen).

2.3. GC × GC-QMS Analysis {#sec2dot3-foods-08-00580}
-------------------------

All GC × GC-QMS applications were carried out on system consisting of a GC2010 gas chromatograph and a QP2010 Ultra quadrupole mass spectrometer (Shimadzu).

The primary column, an SLB-5 ms 30 m × 0.25 mm ID × 0.25 μm d~f~ column (Merck Life Science), was connected to an uncoated capillary segment (1.5 m × 0.18 mm ID, used to create a double-loop), using an SGE SilTite mini-union (Trajan, Ringwood, Victoria, Australia). The uncoated capillary was then connected to a segment of Supelcowax-10 (100% polyethylene glycol) 1.0 m × 0.10 mm ID × 0.10 μm d~f~ column (Merck Life Science), using another union (Trajan). Modulation was carried out every 5 s by using a loop-type modulator (under license from Zoex Corporation, Houston, TX, USA). The duration of the hot pulse (400 °C) was 400 ms.

GC oven temperature program: 50 °C to 250 °C at 3 °C min^−1^. Carrier gas, helium, was supplied at an initial pressure of 173.5 kPa (constant linear velocity). Injection temperature: 250 °C.

Injection mode and volume for monoterpene hydrocarbons: split (1:150), 0.4 μL.

Injection mode and volume for sesquiterpene hydrocarbons: split (1:20), 1.0 μL.

Injection mode and volume for oxygenated compounds: split (1:20), 1.0 μL.

Mass spectrometry parameters: the samples were analyzed in the scan mode using a mass range of 40--360 m/z; spectra generation frequency: 33 Hz; interface and ion source temperatures were 250 °C and 200 °C, respectively. MS ionization mode: electron ionization.

Data were collected by GCMS Solution v.4.45 software (Shimadzu, Kyoto, Japan); bidimensional visualization was carried out using ChromSquare v.2.3 software (Shimadzu). The MS database employed was the FFNSC 3.0 (Shimadzu).

3. Results {#sec3-foods-08-00580}
==========

As performed in previous research \[[@B9-foods-08-00580]\], peak identification was carried out through the combined use of MS database spectral searching and LRI information (comparison between the MS database and experimental LRI values). Three levels of identification were defined: level I---a similarity match ≥90% and an experimental LRI value within a ± 5 LRI tolerance window, with respect to the database result; level II---either a similarity match ≥90%, or an experimental LRI value within a ± 5 LRI tolerance window, with respect to the database result (a compound identified in such a manner cannot be characterized by a similarity match \<80%, or an experimental LRI value outside a ± 10 LRI tolerance range); level III---a similarity match \>75% and an experimental LRI value within a ± 15 LRI tolerance window, with respect to the database result. It must be emphasized that pure standard compounds were not used in the present research to confirm peak identity. However, the combined use of LRI data and MS information is nowadays accepted for the identification of essential oil constituents \[[@B12-foods-08-00580]\]. Finally, the main scope of the research was to demonstrate the power of the off-line four-dimensional (4D) method for this type of food sample.

After the LC pre-separation step, the two fractions (hydrocarbons and oxygenates) were reduced in volume (to 100 µL) and then subjected to three GC × GC-QMS analyses; the hydrocarbon fraction was analyzed twice, for the monoterpene (M) and sesquiterpene (S) hydrocarbons. For the latter compounds, present in lower quantities compared to the M hydrocarbons, a higher sample volume and lower split ratio were used. Fifty hydrocarbons were identified, considering the three oils: 46, 47, and 47 hydrocarbons in the Key A, Key B, and Persian lime oils, respectively, as shown in [Table 1](#foods-08-00580-t001){ref-type="table"}. With regard to the oxygenated compounds, an overall number of 103 constituents were identified: 77, 82, and 48 compounds in the Key A, Key B, and Persian lime oils, respectively, as shown in [Table 2](#foods-08-00580-t002){ref-type="table"}. The GC × GC-QMS chromatogram of the oxygenated fraction of the Persian lime oil is shown in four expansions in [Figure 1](#foods-08-00580-f001){ref-type="fig"}A--D. As can be seen, more than half of the detected peaks in [Figure 1](#foods-08-00580-f001){ref-type="fig"}A--D were not assigned.

Considering both the hydrocarbons and oxygenates, a total number of 153 constituents were identified in the three oils: 123, 129, and 95 compounds in the Key A, Key B, and Persian lime oils, respectively, as shown in [Table 1](#foods-08-00580-t001){ref-type="table"} and [Table 2](#foods-08-00580-t002){ref-type="table"}.

4. Discussion {#sec4-foods-08-00580}
=============

The off-line combination of HPLC and GC × GC--QMS, and its application to the detailed qualitative analysis of lime Essential oils (Eos), gave origin to compound-rich chromatograms, due to the possibility of concentrating the two pre-separated fractions (hydrocarbon and oxygenated compounds), and the two fundamental GC × GC characteristics, namely, the enhanced separation power and sensitivity. As mentioned previously, fifty hydrocarbons were identified with the distribution of M, S, and aliphatic hydrocarbons illustrated in the graph reported in [Figure 2](#foods-08-00580-f002){ref-type="fig"}.

As can be observed, also in [Table 1](#foods-08-00580-t001){ref-type="table"}, the hydrocarbon profiles in the three types of lime oils were very similar. Considering the Key A oil, a number of compounds corresponding to 36, 9, and 1 were identified at levels I, II, and III, respectively; with regard to the Key B oil, a number of compounds corresponding to 32, 14, and 1 were identified at levels I, II, and III, respectively; finally, in the Persian oil, 38 and 9 compounds were identified at levels I and II, respectively. It is noteworthy that the LRI values were calculated by considering the total retention time (sum of the first and second dimension retention times) of the most intense modulated peak of both the alkanes and the lime oil hydrocarbons. Furthermore, the MS database LRI values were derived from analyses performed on the same (low polarity) column, as that used in the first analytical dimension. The retention of both the alkanes and the lime oil hydrocarbons, on the short medium-polarity (100% polyethylene glycol) second dimension, was negligible; for such a reason, there was a general good agreement between experimental and database LRI values.

Six hydrocarbons (all aliphatic) reported in [Table 1](#foods-08-00580-t001){ref-type="table"}, to the best of the present authors' knowledge, have not been previously reported in the literature (an in-depth investigation was carried out) in a cold-extracted lime oil. Furthermore, γ-elemene (a sesquiterpene) was found for the first time in Persian oil, even though it has been reported in Key A and B oils \[[@B2-foods-08-00580],[@B10-foods-08-00580]\]. Five hydrocarbons were found in both types of Key oils (undecane, tetradecane, pentadecane, hexadecane, heptadecane), while six (tetradec-1-ene, tetradecane, γ-elemene, pentadecane, hexadecane, heptadecane) were present in the Persian oil.

The chemical class distribution of the 103 oxygenated compounds identified in the lime oils is illustrated in the graph shown in [Figure 3](#foods-08-00580-f003){ref-type="fig"}.

The number of identified compounds was higher in the Key oils compared to the Persian one. Considering the Key A oil, a number of compounds corresponding to 46, 54, and 23 were identified at levels I, II, and III, respectively; with regard to the Key B oil, a number of compounds corresponding to 36, 73, and 20 were identified at levels I, II, and III, respectively; finally, in the Persian oil, 41, 46, and 8 compounds were identified at levels I, II, and III, respectively. Compared to the hydrocarbons, and in percentage terms, many more compounds were identified at levels II and III. Such an occurrence was, in part, due to the strong interaction of specific oxygenated compounds (e.g., alcohols) on the second dimension column, causing an increased divergence between the experimental and database LRIs.

After an in-depth investigation in the literature, no information was found on 65 compounds present in [Table 2](#foods-08-00580-t002){ref-type="table"} and related to cold-pressed lime oil. Additionally, no previous description was found for the presence of tridecanal in Key B oil, even though it was identified in all the three oils \[[@B2-foods-08-00580]\]. Finally, (*E*)-nerolidol (a sesquiterpene alcohol) and dodecyl acetate were found in all the three oils, even though they have not been previously related to Persian lime oil \[[@B2-foods-08-00580]\].

To conclude, the applied LC//GC × GC-QMS method has enabled the in-depth elucidation of the chemical profile of three types of cold-pressed lime essential oils. The proposed method allows the formation of highly informative and ordered elution patterns that can be exploited for the creation of a fingerprint database as a support for quality assurance.

To the best of the authors' knowledge, many volatiles are here related to such samples for the first time. It cannot obviously be excluded that, in cases, peak identification may not be correct (especially for level III identifications), and that compounds present in the literature related to cold-pressed lime oil have been missed. Even so, the 4D method herein proposed is a powerful analytical not only for citrus (and non-citrus) essential oil analysis, but also in other areas of food research. For example, the 4D technology has been used for the determination of mineral oil contamination in baby foods \[[@B13-foods-08-00580]\].
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![Four GC × GC-QMS chromatogram expansions (**A**--**D**) relative to the analysis of the oxygenated fraction of Persian lime oil (refer to [Table 2](#foods-08-00580-t002){ref-type="table"} for peak identification).](foods-08-00580-g001){#foods-08-00580-f001}

![Graph illustrating the number and chemical class of the hydrocarbons identified in the three lime oil samples.](foods-08-00580-g002){#foods-08-00580-f002}

![Graph illustrating the number and chemical class of the oxygenated compounds identified in the three lime oil samples.](foods-08-00580-g003){#foods-08-00580-f003}

foods-08-00580-t001_Table 1

###### 

Hydrocarbons identified in the three types of cold-pressed lime essential oils, along with experimental and database linear retention index (LRI) values (exp./data LRI).

  Peak   Hydrocarbon                     Exp./Data LRI   Identification LEVEL                     
  ------ ------------------------------- --------------- ---------------------- -------- -------- -----
  1      Nonane ^a,b^                    902/900         \-                     I        \-       Ali
  2      *α*-Thujene ^c^                 927/927         I                      I        I        M
  3      *α*-Pinene ^c^                  933/933         I                      I        I        M
  4      Camphene ^c^                    953/953         I                      I        I        M
  5      Sabinene ^c^                    973/972         I                      I        I        M
  6      *β*-Pinene ^c^                  980/978         I                      I        I        M
  7      Myrcene ^c^                     988/991         I                      I        I        M
  8      *α*-Phellandrene ^c^            1009/1007       I                      I        I        M
  9      *α*-Terpinene ^c^               1018/1018       I                      I        I        M
  10     *p*-Cymene ^c^                  1025/1025       I                      I        I        M
  11     Limonene ^c^                    1030/1030       I                      I        I        M
  12     β-Phellandrene                  1045/1031       II ^c^                 II ^d^   II ^c^   M
  13     (E)-β-Ocimene ^c^               1047/1046       I                      I        I        M
  14     γ-Terpinene ^c^                 1059/1058       I                      I        I        M
  15     Terpinolene ^c^                 1087/1086       I                      I        I        M
  16     Undecane ^e^                    1100/1100       II                     II       \-       Ali
  17     Tridecane                       1299/1300       I ^c^                  I ^c^    I ^a^    Ali
  18     *δ*-Elemene ^c^                 1336/1335       I                      I        I        S
  19     *α*-Cubebene ^a^                1353/1349       II                     II       \-       S
  20     *α*-Copaene ^a^                 1381/1375       II                     II       II       S
  21     *β*-Elemene ^c^                 1387/1390       I                      I        I        S
  22     Tetradec-1-ene ^e,b^            1391/1392       \-                     \-       II       Ali
  23     Tetradecane ^e^                 1398/1400       I                      II       I        Ali
  24     (*Z*)-*α*-Bergamotene ^a^       1416/1416       I                      I        I        S
  25     *α*-Santalene ^a^               1422/1418       I                      II       I        S
  26     (*E*)-Caryophyllene ^c^         1426/1424       I                      I        I        S
  27     *γ*-Elemene                     1434/1432       I ^c^                  I ^c^    I ^e^    S
  28     (*E*)-*α*-Bergamotene           1436/1432       I ^a^                  I ^a^    I ^c^    S
  29     *α*-Himachalene ^a^             1440/1449       I                      II       I        S
  30     (*E*)-*β*-Farnesene ^c^         1452/1452       I                      I        I        S
  31     *α*-Humulene ^c^                1462/1454       II                     II       II       S
  32     Sesquisabinene ^a^              1456/1455       I                      II       I        S
  33     *β*-Santalene ^c,b^             1464/1459       \-                     \-       II       S
  34     *β*-Chamigrene ^a^              1476/1479       II                     II       II       S
  35     *γ*-Curcumene ^a^               1481/1482       I                      I        I        S
  36     *α*-Curcumene ^a^               1483/1480       \-                     \-       II       S
  37     Germacrene D ^a^                1487/1480       II                     II       II       S
  38     (*E*)-*β*-Bergamotene ^a^       1488/1483       II                     II       I        S
  39     Valencene ^a^                   1490/1492       I                      I        I        S
  40     *β*-Selinene                    1497/1492       I ^c^                  I ^c^    I ^a^    S
  41     Pentadecane ^e^                 1498/1500       III                    III      I        Ali
  42     (*Z*)-*α*-Bisabolene ^a^        1503/1503       I                      I        I        S
  43     (*E*, *E*) -*α*-Farnesene ^c^   1505/1504       I                      I        I        S
  44     *β*-Bisabolene ^c^              1509/1508       I                      I        I        S
  45     (*Z*)-*γ*-Bisabolene ^a^        1511/1515       I                      I        I        S
  46     (*E*)-*γ*-Bisabolene ^a^        1530/1528       I                      II       I        S
  47     (*E*)-*α*-Bisabolene ^a^        1541/1540       I                      I        I        S
  48     Germacrene B ^c^                1556/1557       I                      I        II       S
  49     Hexadecane ^e^                  1598/1600       II                     II       I        Ali
  50     Heptadecane ^e^                 1699/1700       I                      I        I        Ali

Abbreviations: M: monoterpene; Ali: aliphatic; S: sesquiterpene. ^a^ Compound not yet identified in cold-extracted laboratory oils \[[@B2-foods-08-00580],[@B10-foods-08-00580]\]. ^b^ Compound identified in only one of the samples. ^c^ Compound identified previously in industrially cold-extracted lime oils and cold-extracted laboratory oils, reported since 1980 \[[@B2-foods-08-00580],[@B10-foods-08-00580]\]. ^d^ Compound identified previously only in cold-extracted laboratory oils \[[@B2-foods-08-00580],[@B10-foods-08-00580]\]. ^e^ Compound, to the best of the authors' knowledge, identified for the first time in an industrially cold-extracted lime oil.

foods-08-00580-t002_Table 2

###### 

Oxygenated compounds identified in the three types of cold-pressed lime essential oils, along with experimental and database LRI values (exp./data LRI).

  Peak   Oxygenated Compound                    Exp./Data LRI   Identification Level                      
  ------ -------------------------------------- --------------- ---------------------- -------- --------- --------
  51     Pinacol ^a^                            862/858         III                    III      \-        AliA
  52     6-methyl-5-hepten-2-one ^b^            985/986         I                      II       \-        AliK
  53     Octanal ^c^                            1006/1006       I                      I        \-        AliAld
  54     Eucalyptol ^a^                         1036/1032       II                     \-       II        MA
  55     (*Z*)-Sabinene hydrate ^c^             1074/1069       II                     II       II        MA
  56     Octanol ^c^                            1074/1076       II                     \-       \-        AliA
  57     Linalool ^c^                           1101/1101       I                      I        I         MA
  58     (*E*)-Sabinene hydrate ^c^             1105/1099       II                     \-       \-        MA
  59     Nonanal ^c^                            1106/1107       II                     II       II        AliAld
  60     (*E*)-Pinene hydrate ^a^               1111/1121       \-                     II       II        MA
  61     Endo-fenchol ^b,d^                     1126/1119       \-                     II       \-        MA
  62     (*E*)-*p*-Mentha-2,8-dien-1-ol ^a^     1128/1122       II                     III      \-        MA
  63     (*E*)-*p*-Menth-2-en-1ol               1129/1139       III ^b^                II ^b^   II ^c^    MA
  64     (*3E,6Z*) -Nonadienol ^a,d^            1141/1152       \-                     III      \-        AliA
  65     (*Z*)-Limonene oxide ^c^               1142/1134       II                     \-       II        MO
  66     (*E*)-Limonene oxide ^c^               1142/1138       II                     \-       \-        MO
  67     (*Z*)-*p*-Mentha-2,8-dien-1-ol ^a,d^   1142/1138       \-                     II       \-        MA
  68     (*E*)-Myroxide ^a^                     1147/1141       III                    \-       \-        MO
  69     (*E*)-Pinocarveol ^b^                  1147/1141       \-                     II       II        MA
  70     Citronellal ^c^                        1154/1152       II                     II       II        MAld
  71     Camphor ^a,d^                          1154/1149       \-                     III      \-        MK
  72     Isopulegol ^a^                         1154/1149       III                    II       II        MA
  73     (*Z*)-Non-3-en-1-ol ^a,d^              1163/1153       \-                     III      \-        AliA
  74     Camphene hydrate ^a,d^                 1163/1156       \-                     II       \-        MA
  75     Pinocarvone ^a^                        1168/1164       II                     II       \-        MK
  76     Non-(*2Z*)-enol ^a,d^                  1171/1170       \-                     III      \-        AliA
  77     Rose furan oxide ^a^                   1172/1169       II                     II       \-        MO
  78     Borneol                                1179/1173       II ^b^                 II ^b^   II ^c^    MA
  79     Isogeranial ^a^                        1182/1179       III                    II       II        MAld
  80     (*Z*)-Pinocamphone ^b,d^               1182/1176       II                     \-       \-        MK
  81     Terpinen-4-ol ^c^                      1186/1180       II                     II       II        MA
  82     (*Z*)-Pinocarveol ^a^                  1188/1186       \-                     II       \-        MA
  83     *p*-Cymen-8-ol                         1192/1189       II ^a^                 II ^b^   III ^a^   MA
  84     Non-(*6Z*)-enal ^a,d^                  1196/1206       III                    \-       \-        AliAld
  85     *α*-Terpineol ^c^                      1200/1195       I                      I        I         MA
  86     Dec-(*4Z*)-enal ^a,d^                  1196/1196       \-                     II       \-        AliAld
  87     (*Z*)-Piperitol ^a^                    1207/1198       III                    II       \-        MA
  88     *neo*-Dihydro carveol ^a,d^            1203/1198       II                     \-       \-        MA
  89     Decanal ^c^                            1207/1208       III                    II       II        AliAld
  90     (*E*)-Piperitol ^e,d^                  1216/1208       \-                     II       \-        MA
  91     Nerol ^c^                              1231/1229       I                      II       II        MA
  92     3,7-dimethyl-Oct-7-enol ^a,d^          1231/1228       \-                     \-       III       AliA
  93     Neral ^c^                              1242/1238       I                      II       I         MAld
  94     Carvone ^a^                            1249/1246       II                     \-       II        MK
  95     Linalyl acetate ^a^                    1250/1250       III                    II       \-        ME
  96     Geraniol ^c^                           1256/1255       II                     II       II        MA
  97     Piperitone ^b^                         1260/1267       II                     II       \-        MK
  98     Geranial ^c^                           1272/1268       I                      II       II        MAld
  99     Perilla aldehyde ^c^                   1282/1278       I                      II       II        MAld
  100    Dihydro-linalool acetate ^a,d^         1286/1275       \-                     II       \-        ME
  101    Dec-2-en-1-ol ^a,d^                    1284/1270       III                    \-       \-        AliA
  102    *iso*-Isopulegyl acetate ^a^           1289/1286       II                     II       \-        ME
  103    Thujyl acetate ^a^                     1289/1298       \-                     II       II        ME
  104    (*Z*)-Verbenyl acetate ^a^             1290/1278       III                    II       \-        ME
  105    (*E*)-Pinocarvyl acetate ^a^           1298/1296       II                     II       \-        ME
  106    Geranyl formate ^d,e^                  1298/1300       II                     \-       \-        ME
  107    Undecanal ^c^                          1307/1309       II                     II       II        AliAld
  108    Isoascaridole ^a^                      1309/1306       II                     II       II        MO
  109    Deca-(*2E,4E*)-dienal ^a^              1321/1322       III                    II       \-        AliAld
  110    Methyl geranate ^a^                    1322/1326       II                     II       \-        ME
  111    Myrtenyl acetate ^a^                   1326/1326       II                     II       \-        ME
  112    Citronellyl acetate ^c^                1349/1350       II                     II       \-        ME
  113    *neo-iso*-Carvomenthyl acetate ^a,d^   1349/1350       \-                     \-       II        ME
  114    Neryl acetate ^c^                      1359/1361       II                     II       II        ME
  115    (*E*)-Myrtanol acetate ^a,d^           1372/1387       II                     \-       \-        ME
  116    Geranyl acetate ^c^                    1378/1380       I                      II       II        ME
  117    (*Z*)-Trimenal ^a,d^                   1435/1424       \-                     III      \-        AliAld
  118    Dodecanal ^c^                          1411/1410       II                     II       II        AliAld
  119    (*E*)-Nerone ^a,d^                     1435/1440       III                    \-       \-        MK
  120    (*E*)-Trimenal ^a,d^                   1435/1424       \-                     III      \-        AliAld
  121    Geranyl isobutyrate ^a^                1506/1507       III                    III      \-        ME
  122    Tridecanal                             1512/1516       II ^b^                 II ^a^   II ^c^    AliAld
  123    (*Z*)-Nerolidol ^a^                    1544/1531       \-                     III      \-        SA
  124    (*E*)-Nerolidol                        1551/1561       III ^e^                II ^e^   III ^a^   SA
  125    Hedycaryol ^a^                         1554/1544       II                     II       \-        SA
  126    Longipinanol ^a^                       1558/1572       III                    III      \-        SA
  127    (*E*)-Sesquisabinene hydrate ^a^       1584/1576       II                     II       \-        SA
  128    Caryophyllene oxide ^c^                1592/1587       III                    II       \-        SO
  129    Dodecyl acetate                        1607/1610       II ^e^                 II ^c^   II ^a^    AliE
  130    Tetradecanal ^c^                       1614/1614       II                     II       II        AliAld
  131    Humulene epoxide II ^a,d^              1619/1613       III                    \-       \-        SO
  132    (*Z*)-Sesquilavandulol ^a^             1623/1610       III                    III      III       SA
  133    (*E*)-Sesquilavandulol ^a^             1639/1633       II                     II       II        SA
  134    (*E*)-Tetradec-2-enal ^a,d^            1668/1673       \-                     \-       III       AliAld
  135    (*Z*)-Nerolidyl acetate ^a,d^          1664/1665       II                     \-       \-        SE
  136    *epi-α*-Bisabolol ^a,d^                1664/1679       \-                     III      \-        SA
  137    Isobornyl isobutanoate-8-hydroxy ^a^   1668/1676       II                     II       \-        ME
  138    *neo*-Intermedeol ^a^                  1668/1661       II                     II       \-        SA
  139    *β*-Bisabolol ^a^                      1677/1677       II                     II       II        SA
  140    (*Z*)-Apritone ^a^                     1688/1687       I                      II       II        SK
  141    *α*-Bisabolol ^c^                      1693/1688       II                     I        II        SA
  142    (*E*)-Apritone ^a^                     1713/1710       II                     II       \-        SK
  143    (*2E,6Z*) - Farnesal ^a,d^             1713/1714       \-                     \-       II        SAld
  144    Tridec-2-en-1-ol acetate ^a^           1715/1705       III                    III      III       AliE
  145    Hernianin ^a,d^                        1735/1720       \-                     III      \-        Other
  146    (*E, E*) -Farnesal ^a^                 1739/1737       II                     II       II        SAld
  147    Hexadec-(*11Z*)-enal ^a^               1817/1808       II                     II       II        AliAld
  148    Farnesyl acetate ^a,\ d^               1832/1832       \-                     III      \-        SE
  149    Hexadec-(*11E*)-en-1-ol ^a,d^          1879/1869       \-                     III      \-        AliA
  150    Cyclohexadecanolide ^a^                1920/1935       III                    III      III       AliE
  151    Citropten ^a^                          1991/1982       II                     II       II        Other
  152    Octadec-(*13Z*)-enal ^a^               1998/2010       III                    III      III       AliAld
  153    Isopimpinellin ^a,\ d^                 2239/2239       \-                     \-       II        Other

Abbreviations: Ali, aliphatic; K, ketone; Ald, aldehyde; E, ester; O, oxide; A, alcohol. ^a^ Compound, to the best of the authors' knowledge, identified for the first time in an industrially cold-extracted lime oil. ^b^ Compound not yet identified in cold-extracted laboratory oils \[[@B2-foods-08-00580]\]. ^c^ Compound identified previously in industrially cold-extracted lime oils and cold-extracted laboratory oils, reported since 1980 \[[@B2-foods-08-00580]\]. ^d^ Compound identified in only one of the samples. ^e^ Compound identified previously only in cold-extracted laboratory oils \[[@B2-foods-08-00580]\].
